Last updated: January 17, 2023
Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India
Overall Status: Completed
Phase
N/A
Condition
Circulation Disorders
Vascular Diseases
Dizzy/fainting Spells
Treatment
N/AClinical Study ID
NCT05548920
SCV IVC Collapsibility
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients belonging to ASA Grade I,II,III
- For major Oncosurgery under general anaesthesia
Exclusion
Exclusion Criteria:
- Patient refusal
- BMI>30
- Emergency surgery
- Preoperative Hypotension MAP < 70 mmHg
- LVEF<40%
- Difficult Airway
- Nasal Intubation
- Inability to obtain good ultrasound images of SCV and IVC .
Study Design
Total Participants: 120
Study Start date:
June 26, 2021
Estimated Completion Date:
January 10, 2023
Study Description
Connect with a study center
Rajiv Gandhi Cancer Institute and Research Centre
New Delhi, Delhi 110085
IndiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.